Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × matuzumab × Clear all

NCT00111839 2018-04-06

Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer

Phase 2 Completed

150 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms